Product image of Olwexya (Venlafaxine) supplied by GNH India

Olwexya

Active Ingredient:
Venlafaxine
Origin:
EU

Olwexya (Venlafaxine)

Venlafaxine, the active ingredient in Olwexya, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as a oral tablet for oral use. It is prescribed for major depressive disorder and other mood‑related conditions in adults.

GNH India supplies Olwexya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olwexya is an SNRI that acts on neurotransmitter pathways involved in mood regulation.

  • Major depressive disorder: alleviates depressive symptoms and improves functional outcomes.
  • Generalized anxiety disorder: reduces anxiety levels and associated physical symptoms.
  • Social anxiety disorder: helps decrease social fear and avoidance behaviours.
  • Panic disorder: lessens the frequency and intensity of panic attacks.

How It Works

  • Venlafaxine inhibits the reuptake of serotonin and norepinephrine, increasing their concentrations in the synaptic cleft. At higher doses it also modestly blocks dopamine reuptake. This combined neurotransmitter enhancement restores balance in brain circuits that regulate mood, anxiety, and pain perception.

Side Effects

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Dry mouth: reduced salivation causing throat discomfort.
  • Insomnia: difficulty falling or staying asleep.
  • Dizziness: transient light‑headedness, especially on standing.
  • Sweating: increased perspiration without exertion.
  • Constipation: slowed intestinal transit.

Serious or Rare Side Effects

  • Hypertensive crisis: sudden, severe elevation in blood pressure.
  • Serotonin syndrome: potentially life‑threatening condition with agitation, hyperreflexia, and fever.
  • Suicidal thoughts: emergence or worsening of suicidal ideation.
  • Severe liver injury: jaundice, elevated enzymes, or hepatic failure.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.

Precautions & Warnings

When prescribing Olwexya, clinicians should consider several safety factors.

  • Cardiovascular assessment: evaluate blood pressure and heart rate before initiation.
  • Psychiatric monitoring: watch for worsening depression or emergence of suicidal thoughts.
  • Drug discontinuation: taper gradually to avoid discontinuation syndrome.
  • Pregnancy and lactation: assess risk‑benefit, as safety data are limited.
  • Drug interactions: review concomitant serotonergic agents.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Olwexya can interact with several medication classes, requiring careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome.
  • Linezolid or rifampicin: additive serotonergic effects.
  • Triptans: increased serotonin activity may precipitate serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask tachycardia from serotonergic effects.
  • NSAIDs: heightened risk of gastrointestinal bleeding.
  • Diuretics: potential for enhanced hypotensive response.

Frequently Asked Questions

Olwexya contains venlafaxine, an SNRI that is commonly prescribed for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder in adult patients. It helps improve mood, reduce anxiety symptoms, and lessen the frequency of panic attacks when used as part of a comprehensive treatment plan.

Venlafaxine blocks the reuptake of serotonin and norepinephrine, increasing their levels in the synaptic cleft. This enhances neurotransmission in pathways that regulate mood and anxiety. At higher doses, it also modestly inhibits dopamine reuptake, contributing to its therapeutic effects.

The appropriate dose of Olwexya is determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage may be adjusted over time, and any changes should be made under medical supervision.

Safety data for venlafaxine in pregnancy and lactation are limited. Clinicians should weigh potential benefits against risks and consider alternative therapies when possible. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment options with their healthcare provider.

To request Olwexya, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Olwexya (venlafaxine) is an SNRI, differing from selective serotonin reuptake inhibitors (SSRIs) by also increasing norepinephrine levels. This broader neurotransmitter effect can be advantageous for patients who do not respond fully to SSRIs, but it may also be associated with a distinct side‑effect profile that requires monitoring.

Olwexya should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight, and extreme temperature fluctuations to maintain product stability.

Olwexya is taken orally, usually as a tablet, with or without food. The exact administration schedule—such as once daily or divided doses—should follow the prescribing clinician’s instructions.

Serious risks include hypertensive crisis, serotonin syndrome, emergence or worsening of suicidal thoughts, severe liver injury, and allergic reactions such as anaphylaxis. Patients should be monitored closely for these events, especially during treatment initiation or dose changes.

Olwexya is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or those with known hypersensitivity to venlafaxine or any tablet excipients. Caution is also advised for individuals with uncontrolled hypertension, severe liver impairment, or a history of serotonin syndrome.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Venlafaxine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT